NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Zuyderland Medisch Centrum
Conditions: Multiple Sclerosis
Interventions: Brain MRI (3T, 7T, 9.4T)
Countries: Netherlands
The MRI scan is one of the most important tools for diagnosing multiple sclerosis (MS) and for monitoring disease progression and medication effects. Increasingly strong MRI magnets (higher field strength) enable us to see abnormalities in the brain in greater detail. On the other hand, it poses challenges because these higher field strength MRIs are more sensitive to disturbances, for example due to motion, including physiological motion such as breathing and swallowing. In current practice, field strengths of up to 3 Tesla are common. The aim of this study is to compare scanning at field strengths of 3 Tesla in 10 MS patients at two different moments (baseline and 6 months) with scanning at field strengths that are higher, namely 7 and 9.4 Tesla, in order to identify the advantages and disadvantages. With the further development of this technique, the investigators may be able to make a better diagnosis in the future and detect subtle changes in the course of the disease more quickly in order to optimize treatments.
Sex: ALL
Age: 18 Years to 65 Years
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Relapsing remitting MS patients (according to the 2017 McDonald criteria) * Age 18-65 years * New brain MRI lesion in the past 15 months. Exclusion Criteria: * Non-compatible implanted material/devices * Not being able to lie flat long enough (for the MRI) because of another medical condition
- Geleen, Limburg, Netherlands